PATH | VRL
Menu

Cross-Protection Against H7N9 Influenza Strains Using a Live-Attenuated H7N3 Virus Vaccine

This article, published in Vaccine, reports the results of a study examining cross-protection of a H7N3 live attenuated influenza vaccine (LAIV) against avian H7N9 influenza viruses in an animal model. Currently no vaccine targeting the new H7N9 influenza viruses exist, so existing vaccines that also provide protection to these new strains are needed. The results showed that the existing H7N3 LAIV protected ferrets from the H7N9 avian influenza viruses. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author: Carter DM, Bloom CE, Kirchenbaum GA, et al.

Published: 2015

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Carter DM, Bloom CE, Kirchenbaum GA, et al. Cross-Protection Against H7N9 Influenza Strains Using a Live-Attenuated H7N3 Virus Vaccine. Vaccine. 2015;33(1):108-116. 

Resource types: Peer-reviewed journal

Diseases/vaccines: Influenza

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Eastern Europe